Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group a streptococci from children with acute pharyngitis.

To evaluate the efficacy of oral penicillin V and intramuscular benzathine penicillin G (BPG) in eradicating group A streptococci from the upper respiratory tract.
Two randomized, single-blind, multicenter antibiotic efficacy trials in children using recommended doses of either oral penicillin V or intramuscular BPG for treatment of acute-onset pharyngitis associated with isolation of group A streptococci were conducted. Throat examinations and cultures were obtained at enrollment and on days 5 to 8, 10 to 14, and 29 to 31.
Thirty-five percent of 284 evaluable patients treated with oral penicillin V and 37% of BPG-treated patients were microbiologic treatment failures at either 10 to 14 or 29 to 31 days.
Although these findings do not provide sufficient evidence to change current treatment recommendations or public health policy, important questions are raised about currently recommended penicillin doses, about the role of the carrier state, and possibly about adequate bioavailability of intramuscular BPG. These findings require confirmation.
AuthorsE L Kaplan, D R Johnson
JournalPediatrics (Pediatrics) Vol. 108 Issue 5 Pg. 1180-6 (Nov 2001) ISSN: 1098-4275 [Electronic] United States
PMID11694700 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Penicillins
  • Penicillin G Benzathine
  • Penicillin V
  • Acute Disease
  • Administration, Oral
  • Carrier State (drug therapy, microbiology)
  • Child
  • Child, Preschool
  • Humans
  • Injections, Intramuscular
  • Penicillin G Benzathine (administration & dosage, pharmacology)
  • Penicillin V (administration & dosage, pharmacology)
  • Penicillins (administration & dosage, pharmacology)
  • Pharyngitis (drug therapy, microbiology)
  • Single-Blind Method
  • Streptococcal Infections (drug therapy, microbiology)
  • Streptococcus pyogenes
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: